EPIX Essa Pharma Inc

Price (delayed)

$5.31

Market cap

$235.57M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.63

Enterprise value

$143.98M

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in ...

Highlights
The company's debt has surged by 143% YoY but it fell by 6% QoQ
The EPS has decreased by 7% QoQ but it has increased by 4.5% YoY
EPIX's quick ratio has dropped by 55% year-on-year and by 19% since the previous quarter
EPIX's equity is down by 15% year-on-year and by 5% since the previous quarter

Key stats

What are the main financial stats of EPIX
Market
Shares outstanding
44.36M
Market cap
$235.57M
Enterprise value
$143.98M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.76
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$27.73M
EBITDA
-$27.63M
Free cash flow
-$21.42M
Per share
EPS
-$0.63
Free cash flow per share
-$0.48
Book value per share
$3.02
Revenue per share
$0
TBVPS
$3.12
Balance sheet
Total assets
$137.9M
Total liabilities
$4.43M
Debt
$353,662
Equity
$133.47M
Working capital
$133.12M
Liquidity
Debt to equity
0
Current ratio
32.89
Quick ratio
32.67
Net debt/EBITDA
3.31
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-19%
Return on equity
-19.5%
Return on invested capital
-29.9%
Return on capital employed
-20.7%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EPIX stock price

How has the Essa Pharma stock price performed over time
Intraday
3.31%
1 week
-5.35%
1 month
8.37%
1 year
86.32%
YTD
-19.55%
QTD
0.95%

Financial performance

How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$34.15M
Net income
-$27.73M
Gross margin
N/A
Net margin
N/A
EPIX's operating income is down by 7% since the previous quarter and by 5% year-on-year
The net income has contracted by 7% from the previous quarter but it has grown by 4.2% YoY

Growth

What is Essa Pharma's growth rate over time

Valuation

What is Essa Pharma stock price valuation
P/E
N/A
P/B
1.76
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has decreased by 7% QoQ but it has increased by 4.5% YoY
The stock's price to book (P/B) is 20% less than its 5-year quarterly average of 2.2 but 3.5% more than its last 4 quarters average of 1.7
EPIX's equity is down by 15% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Essa Pharma business performance
EPIX's return on invested capital is down by 28% since the previous quarter and by 12% year-on-year
EPIX's ROE is down by 12% from the previous quarter and by 11% YoY
EPIX's return on assets is down by 12% since the previous quarter and by 10% year-on-year

Dividends

What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EPIX.

Financial health

How did Essa Pharma financials performed over time
The company's total liabilities has surged by 104% YoY and by 16% QoQ
The company's current ratio has shrunk by 55% YoY and by 19% QoQ
The company's debt is 100% lower than its equity
The company's debt has surged by 143% YoY but it fell by 6% QoQ
EPIX's equity is down by 15% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.